SKI Market

Indian Indices

Nifty

22,055.20 97.70
(0.44%)

Sensex

72,664.47 260.30
( 0.36%)

Bank Nifty

47,421.10 -66.80
( -0.14%)

Nifty IT

32,935.15 -270.70
( -0.82%)

Global Indices

Nasdaq

16,346.27 43.51
(0.27%)

Dow Jones

39,387.76 331.37
(0.85%)

Hang Seng

18,963.68 425.87
(2.30%)

Nikkei 225

38,229.11 155.13
(0.41%)

Forex

USD-INR

83.47 0.00
(-0.01%)

EUR-INR

89.79 -0.06
(-0.07%)

GBP-INR

104.34 -0.31
(-0.29%)

JPY-INR

0.54 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01023

1453.1267897

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.59

98073.29

EPS(TTM)

Face Value()

Div & Yield %

260.28

0.68

Back

Atishay standalone net profit rises 575.00% in the December 2023 quarter

Jan 22,2024

Net profit of Atishay rose 575.00% to Rs 1.89 crore in the quarter ended December 2023 as against Rs 0.28 crore during the previous quarter ended December 2022. Sales rose 95.67% to Rs 11.76 crore in the quarter ended December 2023 as against Rs 6.01 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	11.76	6.01	96
OPM %	23.04	6.66	-
PBDT	3.09	0.78	296
PBT	2.68	0.42	538
NP	1.89	0.28	575

22,055.20 97.70 (0.44%)

72,664.47 260.30 ( 0.36%)

47,421.10 -66.80 ( -0.14%)

32,935.15 -270.70 ( -0.82%)

16,346.27 43.51 (0.27%)

39,387.76 331.37 (0.85%)

18,963.68 425.87 (2.30%)

38,229.11 155.13 (0.41%)

83.47 0.00 (-0.01%)

89.79 -0.06 (-0.07%)

104.34 -0.31 (-0.29%)

0.54 0.00 (-0.73%)